Registration for a live webinar on 'Phasing Out Animal Testing: A New Era for Pharmaceutical Innovation' is now open.
See webinar details
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Luminal Gastroenterology
-
31 min
1. Novel treatments for GI malignancies- Prof. Bert H. O'Neil
-
40 min
2. The spectrum of GERD implications for assessment and management- Prof. Eamonn M. M. Quigley
-
54 min
3. Oro-pharyngeal and esophageal motility and dysmotility- Dr. John E. Pandolfino
-
55 min
4. Eosinophilic esophagitis and other non-reflux esophageal disorders- Prof. David Katzka
-
39 min
-
17 min
-
48 min
-
48 min
8. Gastric cancer, gastritis and the role of H. pylori- Prof. Anthony Axon
-
48 min
9. Celiac disease- Prof. Ciaran Kelly
-
43 min
10. IBD for the non-gastroenterologist- Prof. Sunanda Kane
-
34 min
11. The enteric microbiota in health and disease- Dr. Francisco Guarner
-
45 min
12. Colorectal cancer and hereditary colon cancer syndromes- Prof. Carol A. Burke
-
39 min
13. The spectrum of GI ischemia 1- Prof. Lawrence J. Brandt
-
31 min
14. The spectrum of Gl ischemia 2- Prof. Lawrence J. Brandt
-
41 min
15. Constipation and defecation disorders- Prof. Satish S. C. Rao
-
40 min
16. Diverticular disease of the colon- Dr. Dale Vimalachandran
-
73 min
17. Irritable bowel syndrome (IBS)- Prof. Eamonn M. M. Quigley
-
27 min
18. Evidence-based management of non-variceal upper GI bleeding- Prof. Joseph J. Sung
- Hepatology
-
32 min
19. Hepatitis B virus (HBV)- Prof. Marco Olivera-Martinez
-
26 min
20. Hepatitis C - cure of infection- Prof. Mark Mailliard
-
46 min
21. Drug-induced liver injury: importance, epidemiology, and mechanisms of DILI- Prof. James H. Lewis
-
26 min
22. Drug-induced liver injury: risk factors and drug development in DILI- Prof. James H. Lewis
-
39 min
23. Drug-induced liver injury: HDS, diagnosing, treating and preventing DILI- Prof. James H. Lewis
-
22 min
24. Portal hypertension- Prof. John Reinus
-
55 min
25. Portal hypertension: at the bedside- Dr. Clara Y. Tow
-
29 min
26. The management of chronic liver disease, including transplantation 1- Prof. Timothy M. McCashland
-
21 min
27. The management of chronic liver disease, including transplantation 2- Prof. Timothy M. McCashland
-
34 min
28. Hereditary hemochromatosis: what have we learnt from population studies- Prof. John K. Olynyk
-
38 min
29. Immune-mediated liver disease- Dr. Jenny Heathcote
-
51 min
30. Alcoholic liver disease- Prof. Michael Lucey
- The Pancreas and Biliary Tree
-
46 min
31. Acute pancreatitis- Prof. Davor Štimac
-
49 min
32. Chronic pancreatitis- Prof. Christopher Forsmark
-
47 min
33. Pancreatic cancer- Prof. Randall Brand
-
20 min
- Archived Lectures *These may not cover the latest advances in the field
-
52 min
35. The management of other aspects of chronic liver disease, including transplantation- Prof. Timothy M. McCashland
-
38 min
36. Chronic viral hepatitis B and C- Prof. Mark Mailliard
-
41 min
37. Pancreatic cancer- Prof. Randall Brand
-
72 min
38. Acute viral hepatitis- Prof. Geoffrey Dusheiko
-
33 min
39. Diverticular disease- Dr. Charles Knowles
-
57 min
40. The spectrum of gastrointestinal ischemia: 2010- Prof. Lawrence J. Brandt
-
51 min
41. Acute pancreatitis- Prof. Davor Štimac
Printable Handouts
Navigable Slide Index
- Introduction
- Pancreatic cancer: overview
- Recent celebrity pancreatic cancer deaths
- The pancreas - an anatomical overview
- Pancreatic adenocarcinoma
- Pancreatic cancer: epidemiology
- Incidence of pancreas cancer
- Pancreatic cancer risk factors
- Role of smoking in pancreatic cancer development
- Pancreatic adenocarcinoma: risk factors moderate
- Pancreatic adenocarcinoma: risk factors high
- President Jimmy Carter's family
- Syndromes associated with pancreatic cancer
- Phenotypic changes of the skin in FAMMM
- Familial atypical multiple mole melanoma pedigree
- Pathology
- Pancreatic adenocarcinoma: precursor lesions
- Genetic progression model of pancreatic cancer
- Ductal adenocarcinoma: gross
- Ductal adenocarcinoma: micro (1)
- Ductal adenocarcinoma: micro (2)
- Ductal adenocarcinoma: micro (3)
- Ductal adenocarcinoma: micro (4)
- Cystic neoplasms
- Serous microcystic adenoma
- Mucinous cystic tumors
- Mucinous cystic neoplasm: gross
- Mucinous cystic neoplasm: micro
- Intraductal Papillary Mucinous Neoplasm (IPMN)
- Types of IPMNs
- IPMN: gross (duct opened)
- IPMN: MRI scan
- Branch duct-IPMN with CIS
- Adenocarcinoma: signs and symptoms (1)
- Adenocarcinoma: signs and symptoms (2)
- The difficulty of finding pancreatic cancer early
- Current status of biomarkers: CA 19-9
- CA 19-9: effects of selecting different cutoff points
- CA 19-9 as screening test
- CA19-9 in symptomatic patients
- Screening versus surveillance
- Conventional techniques
- Sensitivity and specificity of imaging modalities
- Candidates for pancreatic cancer surveillance
- Pancreatic adenocarcinoma: staging (1)
- Pancreatic adenocarcinoma: staging (2)
- Diagnostic algorithm
- Pancreatic adenocarcinoma: staging (3)
- Abdominal CT scan of a pancreatic mass
- CT angiogram of major abdominal vessels
- MRI scan of a pancreatic mass
- MRCP of the biliary ductal system
- Radial and linear echoendoscopes
- Pancreatic-biliary imaging stations
- Imaging stations of the stomach
- Sonography of a mass in the body of pancreas
- Five-year relative survival rates, 1989-1995
- Approach to improve on dismal prognosis
- Prevention of pancreatic cancer
- Treatment of pancreatic cancer
- Stages of pancreatic cancer
- Options for therapy (1)
- Options for therapy (2)
- Treatment: pancreatic adenocarcinoma
- Situations to avoid surgery: pancreatic cancer
- Adjuvant therapy of pancreatic cancer study
- Comparing chemotherapy & chemoradiotherapy (1)
- Comparing chemotherapy & chemoradiotherapy (2)
- Locally unresectable pancreatic cancer
- Pivotal trial of gemcitabine vs. 5-FU
- Mechanism of action of gemcitabine
- Pancreatic carcinoma: treatment
- Pancreatic carcinoma: palliation
- Duodenal obstruction from extrinsic compression
- Placement of an expandable duodenal stent
- Pancreatic head cancer with biliary obstruction
- Pancreatic carcinoma: treatment summary
- Concluding remarks
Topics Covered
- General epidemiologic data for pancreatic cancer
- Review risk factors for pancreatic cancer
- Clinical presentation and diagnostic modalities for pancreatic cancer
- Current status for early detection, diagnosis and staging of pancreatic cancer
- Treatment of pancreatic cancer
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Brand, R. (2011, January 5). Pancreatic cancer [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved March 28, 2025, from https://doi.org/10.69645/OJMD7342.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Randall Brand, Grant/Research Support (Principal Investigator): Ambry Genetics, supplied research support to cover free genetic testing and costs associated with initiating study at our site as part of a multi-center trial. Study was not discussed in the presentation.
